With incoming president Donald Trump threatening a trade war with China, experts told BioSpace that the new administration ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Gilead Sciences and the U.S. government have settled a billion-dollar patent dispute over Gilead's HIV prevention drugs ...

Two moon landers, one from Japan's ispace and another from U.S. space firm Firefly, began their journeys into space on Wednesday (January 15) with SpaceX's unusual double moonshot launch, underscoring ...

Just a week before he vacates the White House, President Biden signed the Interim Final Rule on Artificial Intelligence ...

When the BIOSECURE Act hit a setback and missed the chance of becoming law in 2024, the deceleration of the draft legislation ...

TCW Funds, an investment management company, released its “TCW Relative Value Large Cap Fund” Q3 2024 investor letter. A copy ...

HONG KONG -- Until recently, Chinese consumers and companies did not shy away from foreign brands when buying high-performance cars and trucks for their own use. Windrose Technology is part of a ...

Cat owners in China desperate to save their beloved cats are using human ... Antiviral drugs like GS-441524, developed by ...

China's top drug regulator has recently approved the nation's first stem cell therapy to treat a type of complication associated with bone marrow transplant, as well as a novel HIV drug that only ...

Also on Thursday, China approved lenacapavir, a long-acting HIV drug made by global biopharmaceutical company Gilead Sciences, according to the administration and the company. The treatment is ...